Honored to Partner with LLS Therapy Acceleration Program for Transformative Cancer Therapies – Auron Therapeutics, Inc
OncoDaily GU · Lycoming Career and Technology Center, PA · 2 wk ago
Business DevelopmentFull-time
We’re honored to be supported by The Leukemia & Lymphoma Society through their prestigious Therapy Acceleration Program (TAP)!
LLS TAP’s investment in Auron supports the rapid development of our Phase 1 AUTX-703 for relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes.
Benefits
- Access to LLS’s unparalleled expertise in blood cancer research
- Deep understanding of patient needs
Qualifications
- Experience in blood cancer research
- Understanding of patient needs